This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharmareps. The most desired information doctors now want is about patient assistance programs, with 49% saying they want pharmareps to provide that information. So is the future of HCP marketing digital?
Will patients be happy with telehealth once they feel it’s safe to return to physicians’ offices? Back to HCP’s…digitization can’t replace the relationships that pharmareps and MLS people build with doctors. For HCP marketing it will be PART of the mix but won’t yet replace in-person reps.
OPENING: Pharma companies are starting to embrace digital marketing forced, in large part, by changes brought on by the pandemic. Digital marketing is becoming a valuable tool. Furthermore, only 10% of physicians had met with a pharmaceutical company representative in a hospital. and the U.S.,
As HCPs get more digitally savvy, pharmamarketers should understand that engaging physicians through channels and time of their preference with content relevant to the individual customer. is no more an option but a critical factor to ensure success for any multichannel marketing initiatives.
In conjunction with CMI Media Group’s international expansion beyond the United States, we conducted research and published a report in partnership with Medscape which delved into the media habits of physicians across the EU5 countries: France, Germany, Italy, Spain, and the United Kingdom.
For life sciences commercial teams, effectively engaging physicians and supporting them with education on the evolving science around products and conditions requires a deep understanding of physician content needs and channel preferences. physicians across 15 specialties, treating more than 95 conditions. Among all U.S.
I decided to call some more physicians within my network and ask about online visits from pharmareps. With the CDC relaxing COVID guidelines, one has to wonder when drug reps will start using their company cars that have been idle for over a year. Of course, it really depends on specialty.
SUMMARY: Today, more physicians and patients rely on the Internet to answer their questions about emerging treatments, including prescription drugs. If there is one industry that needs to think more about digital, it’s pharma. This is a severe concern in an era where more HCPs are refusing to meet with pharmareps.
In addition, 62% of HCPs are overwhelmed by product-related promotional content pushed by pharma companies on the various digital channels. I maintain a network of thought leaders in several health conditions, and they all have one thing in common: pharmareps and messages are becoming more irrelevant.
Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for various parts of the system to get to what becomes the steady state – a new way of operating, the new normal. How does the situation impact pharma?
As pharmareps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks.
Point-of-Care marketers had to make a lot of adjustments as the pandemic completely upended the experience of patients seeing their doctor and getting their medications. What will marketers need to do differently? What will be the biggest changes in the point of care marketing space in 2023 and beyond? Focus on Market Research.
A decade ago, pharmareps could easily book in-person meetings with doctors, build lasting relationships, and crush their sales quotas. Physicians are harder to get hold of in 2023. We have yet to talk about the increased level of competition that modern reps have to deal with. Pharmaceutical sales have changed.
Pharmaceutical sales representatives (often times referred to as pharmareps) are hired by pharmaceutical/biotech companies to educate healthcare providers (HCPs) such as physicians, pharmacists, nurses, and physician assistants (PAs) on their company’s product. What’s a day in the life like for a pharmarep?
Also, already before the COVID-19 pandemic, many physicians began to restrict visits from pharmareps in some way, and the majority of offices had variable access policies governing pharmarep visits. Medical device sales reps are facing the same challenges and this is why this subject is so important.
Developed to address ongoing provider burnout head-on, the new practice engagement solution reimagines how clinical care teams communicate and collaborate by providing a centralized hub for physicians and staff. Walters, MHA, NREMT, Practice Director – Tyler Market at Texas Oncology. “We Learn more at patientpoint.com.
Technological advancements, shifting market dynamics, and updated regulations are leading to significant changes within the pharmaceutical industry. Pharmaceutical representatives (pharmareps) are facing new challenges as a result of these transformations that have drastically altered the pharmaceutical sales landscape.
According to Veeva Pulse data , COVID-19 has accelerated the shift to digital for life sciences, with significant growth in remote and digital engagement since early 2020, and a 10X increase of HCPs using three or more channels in their engagement with pharma 1.
One specific product is still fairly new to the market and extremely disruptive in the space. Ophthalmology offices opened quicker than most doctors’ or physicians’ offices did. I would call on physicians during the day. I would say it’s equivalent probably to a pharmarep. We were still very busy.
A series of studies and surveys have documented the fact that substantial numbers of physicians, nurses, and allied health professionals are active on or prefer social media for professional purposes and to connect directly with peers. AI will also help marketers determine what works and what doesn’t.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content